Confirmation of Q1 trading update
CelLBxHealth plc has announced that it will release its trading update for the first quarter of 2026 in mid-May. The company, specializing in circulating tumor cell (CTC) solutions for research, drug development, and clinical oncology, will provide an update on its performance.
Select text to share a quote on X · sign in to keep highlights & notes in your CLBX notes
Guildford, UK and Plymouth Meeting, U.S. - 30 April 2026 - CelLBxHealth plc (AIM: CLBX), a CTC intelligence company specialising in innovative circulating tumor cell (CTC) solutions for use in research, drug development and clinical oncology, announces that it will provide a trading update for Q1 2026 in mid-May.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.